Fosfluconazole for Antifungal Prophylaxis in Very Low Birth Weight Infants

We conducted a retrospective case series study to evaluate the safety of fosfluconazole prophylaxis for preventing invasive fungal infection in VLBW infants with a central vascular access. Fosfluconazole was administered intravenously at a dose of 6 mg/kg everyday during which time a central venous...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Daijiro, Nakamura, Tomohiko, Shigematsu, Reiko, Matsui, Miyu, Araki, Shunsuke, Kubo, Kazuyasu, Sato, Hiroshi, Shirahata, Akira
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2009
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778452/
https://www.ncbi.nlm.nih.gov/pubmed/19946419
http://dx.doi.org/10.1155/2009/274768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778452/
https://www.ncbi.nlm.nih.gov/pubmed/19946419
http://dx.doi.org/10.1155/2009/274768

Ejemplares similares